Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroshi Tsubamoto

Showing results (31-40 of 81) with videos related to

Pageof 9
Sort By:
Anticancer Research|July 1, 2015
Combination Chemotherapy with Itraconazole for Treating Metastatic Pancreatic Cancer in the Second-line or Additional SettingHiroshi Tsubamoto, Takashi Sonoda, Shinichi Ikuta, et al.
Anticancer Research|July 3, 2017
Itraconazole Modulates Hedgehog, WNT/β-catenin, as well as Akt Signalling, and Inhibits Proliferation of Cervical Cancer CellsTomoko Ueda, Hiroshi Tsubamoto, Kayo Inoue, et al.
Journal of Cancer Research and Therapeutics|September 2, 2017
Effectiveness of intraperitoneal or intrapleural administration of triamcinolone acetonide for the control of malignant ascites and pleural effusion (Kansai Clinical Oncology Group-G1102 study)Kimihiko Ito, Hiroshi Tsubamoto, Kayo Inoue, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|June 9, 2016
Effects of gremlin-2 on the transition of primordial follicles during early folliculogenesis in the human ovaryYuki Ikeda, Akiko Hasegawa, Hiroshi Tsubamoto, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 12, 2012
Fertility-sparing management for bulky cervical cancer using neoadjuvant transuterine arterial chemotherapy followed by vaginal trachelectomyHiroshi Tsubamoto, Riichiro Kanazawa, Kayo Inoue, et al.
Anticancer Research|January 2, 2016
Gremlin 2 is Repressed in Invasive Endometrial Cancer and Inhibits Cell Growth In VitroHiroshi Tsubamoto, Kazuko Sakata, Riya Sakane, et al.
Journal of Cancer Research and Therapeutics|January 4, 2020
Phase I study on pegylated liposomal doxorubicin in combination with docetaxel for patients with platinum-resistant or partially platinum-sensitive epithelial ovarian cancer: The Kansai Clinical Oncology Group studyKensuke Hori, Kimihiko Ito, Kentaro Kuritani, et al.
The Journal of Obstetrics and Gynaecology Research|October 15, 2013
¹⁸F-Fluorodeoxyglucose uptake and clinicopathological features of recurrent or metastatic endometrial stromal sarcomaKayo Inoue, Hiroshi Tsubamoto, Shuji Kawata, et al.
Anticancer Research|December 1, 2022
First-Line Gemcitabine, Nab-Paclitaxel, and Oxaliplatin Chemotherapy With Itraconazole in Patients With Metastatic Pancreatic Cancer: A Single Institution ExperienceMiyuki Sawasaki, Hiroshi Tsubamoto, Ayako Sugihara, et al.
Anticancer Research|February 10, 2017
Itraconazole Inhibits AKT/mTOR Signaling and Proliferation in Endometrial Cancer CellsHiroshi Tsubamoto, Kayo Inoue, Kazuko Sakata, et al.
Pageof 9

Showing results (31-40 of 81) with videos related to

Sort By:
Pageof 9
Anticancer Research|July 1, 2015
Combination Chemotherapy with Itraconazole for Treating Metastatic Pancreatic Cancer in the Second-line or Additional SettingHiroshi Tsubamoto, Takashi Sonoda, Shinichi Ikuta, et al.
Anticancer Research|July 3, 2017
Itraconazole Modulates Hedgehog, WNT/β-catenin, as well as Akt Signalling, and Inhibits Proliferation of Cervical Cancer CellsTomoko Ueda, Hiroshi Tsubamoto, Kayo Inoue, et al.
Journal of Cancer Research and Therapeutics|September 2, 2017
Effectiveness of intraperitoneal or intrapleural administration of triamcinolone acetonide for the control of malignant ascites and pleural effusion (Kansai Clinical Oncology Group-G1102 study)Kimihiko Ito, Hiroshi Tsubamoto, Kayo Inoue, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|June 9, 2016
Effects of gremlin-2 on the transition of primordial follicles during early folliculogenesis in the human ovaryYuki Ikeda, Akiko Hasegawa, Hiroshi Tsubamoto, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 12, 2012
Fertility-sparing management for bulky cervical cancer using neoadjuvant transuterine arterial chemotherapy followed by vaginal trachelectomyHiroshi Tsubamoto, Riichiro Kanazawa, Kayo Inoue, et al.
Anticancer Research|January 2, 2016
Gremlin 2 is Repressed in Invasive Endometrial Cancer and Inhibits Cell Growth In VitroHiroshi Tsubamoto, Kazuko Sakata, Riya Sakane, et al.
Journal of Cancer Research and Therapeutics|January 4, 2020
Phase I study on pegylated liposomal doxorubicin in combination with docetaxel for patients with platinum-resistant or partially platinum-sensitive epithelial ovarian cancer: The Kansai Clinical Oncology Group studyKensuke Hori, Kimihiko Ito, Kentaro Kuritani, et al.
The Journal of Obstetrics and Gynaecology Research|October 15, 2013
¹⁸F-Fluorodeoxyglucose uptake and clinicopathological features of recurrent or metastatic endometrial stromal sarcomaKayo Inoue, Hiroshi Tsubamoto, Shuji Kawata, et al.
Anticancer Research|December 1, 2022
First-Line Gemcitabine, Nab-Paclitaxel, and Oxaliplatin Chemotherapy With Itraconazole in Patients With Metastatic Pancreatic Cancer: A Single Institution ExperienceMiyuki Sawasaki, Hiroshi Tsubamoto, Ayako Sugihara, et al.
Anticancer Research|February 10, 2017
Itraconazole Inhibits AKT/mTOR Signaling and Proliferation in Endometrial Cancer CellsHiroshi Tsubamoto, Kayo Inoue, Kazuko Sakata, et al.
Pageof 9